星昊医药
(920017)
| 流通市值：19.83亿 | | | 总市值：20.05亿 |
| 流通股本：1.23亿 | | | 总股本：1.25亿 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 322,400,378.6 | 356,994,165.54 | 430,954,334.41 | 471,463,221.54 |
| 交易性金融资产 | 596,151,021.51 | 484,866,486.32 | 455,639,252.04 | 352,678,306.8 |
| 应收票据及应收账款 | 58,937,465.85 | 52,348,901.73 | 60,914,739.91 | 65,249,122.88 |
| 其中：应收票据 | 6,559,170.61 | 3,261,724.37 | 10,269,247.51 | 12,304,001.79 |
| 应收账款 | 52,378,295.24 | 49,087,177.36 | 50,645,492.4 | 52,945,121.09 |
| 应收款项融资 | 7,023,109.07 | 2,189,510.11 | 3,974,334.05 | 3,365,781.53 |
| 预付款项 | 2,307,485.45 | 1,261,956.29 | 2,880,089.15 | 4,082,699.1 |
| 其他应收款合计 | 3,785,839.68 | 3,641,275.87 | 5,230,407.22 | 3,885,035.59 |
| 存货 | 65,600,589.15 | 74,337,619.71 | 71,561,951.76 | 67,335,220.03 |
| 一年内到期的非流动资产 | - | 43,665,643.83 | 43,356,493.15 | 64,871,671.18 |
| 其他流动资产 | 30,352,024.67 | 25,908,427.96 | 19,337,935.49 | 20,911,783.13 |
| 流动资产合计 | 1,086,557,913.98 | 1,045,213,987.36 | 1,093,849,537.18 | 1,053,842,841.78 |
| 非流动资产: | | | | |
| 长期股权投资 | 3,563,383.08 | 3,805,512.38 | 3,892,392.96 | 3,992,378.48 |
| 其他权益工具投资 | 5,593,964.36 | 5,469,752.78 | 6,318,464.15 | 6,318,464.15 |
| 固定资产 | 585,517,672.86 | 597,520,572.16 | 611,353,874.47 | 623,527,382.01 |
| 在建工程 | 233,599,796.29 | 196,246,567.43 | 184,153,137.96 | 159,393,940.52 |
| 无形资产 | 68,828,540.61 | 69,275,933.61 | 70,473,049.79 | 71,241,752.69 |
| 递延所得税资产 | 28,927,510.78 | 28,950,238.47 | 27,433,467.29 | 26,751,004.08 |
| 其他非流动资产 | 20,354,288.32 | 33,781,710 | 33,700,070 | 27,628,302.71 |
| 非流动资产合计 | 946,385,156.3 | 935,050,286.83 | 937,324,456.62 | 918,853,224.64 |
| 资产总计 | 2,032,943,070.28 | 1,980,264,274.19 | 2,031,173,993.8 | 1,972,696,066.42 |
| 流动负债: | | | | |
| 短期借款 | 10,007,180.56 | 10,007,180.56 | 10,007,180.56 | 10,007,180.56 |
| 应付票据及应付账款 | 94,363,453.5 | 120,737,474.09 | 98,654,618.64 | 84,035,368.33 |
| 其中：应付票据 | 40,652,898 | 31,179,284.35 | 35,392,733.65 | 44,746,217.3 |
| 应付账款 | 53,710,555.5 | 89,558,189.74 | 63,261,884.99 | 39,289,151.03 |
| 合同负债 | 23,963,045.84 | 24,546,863.41 | 21,947,242.26 | 21,039,913.99 |
| 应付职工薪酬 | 5,164,462.31 | 4,997,601.01 | 9,094,692.83 | 12,482,825.24 |
| 应交税费 | 21,241,371.69 | 10,014,376.51 | 11,964,000.83 | 11,890,121.55 |
| 其他应付款合计 | 51,610,042.7 | 51,109,174.76 | 58,025,734.96 | 50,482,203.23 |
| 其他流动负债 | 4,939,258.95 | 4,201,739.02 | 11,594,724.89 | 12,747,264.02 |
| 流动负债合计 | 211,288,815.55 | 225,614,409.36 | 221,288,194.97 | 202,684,876.92 |
| 非流动负债: | | | | |
| 预计负债 | 37,180,618 | 31,991,938.75 | 30,000,000 | 30,000,000 |
| 递延收益 | 85,856,066.67 | 88,033,424.36 | 92,550,403.34 | 84,267,382.21 |
| 递延所得税负债 | 1,855,388.74 | 2,228,523.71 | 2,035,729.56 | 2,231,911.12 |
| 非流动负债合计 | 124,892,073.41 | 122,253,886.82 | 124,586,132.9 | 116,499,293.33 |
| 负债合计 | 336,180,888.96 | 347,868,296.18 | 345,874,327.87 | 319,184,170.25 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 124,507,417 | 123,892,517 | 124,832,280 | 124,832,280 |
| 资本公积 | 745,793,654.17 | 739,158,883.17 | 747,248,865.39 | 747,248,865.39 |
| 减:库存股 | 5,008,441.2 | 5,008,441.2 | 14,741,444.01 | 14,741,444.01 |
| 其他综合收益 | -3,793,427.98 | -3,899,542.58 | -3,176,975.25 | -3,175,802.94 |
| 盈余公积 | 61,399,573.17 | 61,399,573.17 | 61,399,573.17 | 61,399,573.17 |
| 未分配利润 | 773,863,406.16 | 716,852,988.45 | 769,737,366.63 | 737,948,424.56 |
| 归属于母公司股东权益合计 | 1,696,762,181.32 | 1,632,395,978.01 | 1,685,299,665.93 | 1,653,511,896.17 |
| 少数股东权益 | - | - | - | 0 |
| 股东权益合计 | 1,696,762,181.32 | 1,632,395,978.01 | 1,685,299,665.93 | 1,653,511,896.17 |
| 负债和股东权益合计 | 2,032,943,070.28 | 1,980,264,274.19 | 2,031,173,993.8 | 1,972,696,066.42 |
| 公告日期 | 2026-10-28 | 2026-08-10 | 2026-04-29 | 2026-04-24 |
| 审计意见(境内) | | | | 标准无保留意见 |